Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02610101 · ClinicalTrials.gov registry record · NA
Nutritional Therapy Study in Pediatric Crohn's Disease
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02610101: Completed NA study, sponsored by Seattle Children's Hospital.
NCT02610101 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02610101, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The investigators are doing this research study to answer questions about a nutritional therapy called the Specific Carbohydrate Diet (SCD) for children with active Crohn's Disease (CD). The SCDiet is a diet where all grains such as wheat, barley, corn, rice are restricted. Most dairy products (except certain yogurt) are also restricted. The diet mainly consists of meat, fruits, vegetables, nuts, oils and honey, and is offered to individuals with active Crohn's disease as part of standard of care at Seattle Children's. For this study, the investigators will have three different dietary groups: 1. Traditional SCD diet group 2. Modified SCD to include oatmeal and rice 3. SCD with whole foods without added sugar Specifically, the investigators want to know: * Is the SCD well tolerated? * Is SCD effective for the treatment for active Crohn's Disease? * Will the results from the varied three dietary groups have the same results for each patient?
Primary Outcome
Activity Index is a validated form of measurement for disease activity
Interventions
- OTHER Traditional SCD Diet
- OTHER Modified SCD Diet
- OTHER Whole foods diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02610101 record still lists
NCT02610101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Traditional SCD Diet is the first listed.
NCT02610101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02610101 about?
NCT02610101 is a clinical study titled "Nutritional Therapy Study in Pediatric Crohn's Disease". The investigators are doing this research study to answer questions about a nutritional therapy called the Specific Carbohydrate Diet (SCD) for children with active Crohn's Disease (CD). The SCDiet is a diet where all grains such as wheat, barley, corn, rice are restricted. Most dairy products (exce...
What is the current status of trial NCT02610101?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-11. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02610101?
The interventions under investigation include: Traditional SCD Diet (OTHER), Modified SCD Diet (OTHER), Whole foods diet (OTHER).
Who is sponsoring clinical trial NCT02610101?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02610101's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia